More than 25 types of sarcoma and leukemia are characterized by fusion oncogenes formed between one of the FET genes (FUS, EWSR1, or TAF15) as 5′ partner and one of more than 30 alternative transcription factor-coding genes as 3′ partner (1, 2). This evidence concerns the gene EWSR1 and sarcoma.